Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Evaluating exercise response in chronic fatigue syndrome.

Official title: Assessment of Exercise Response in Chronic Fatigue Syndrome / Myalgic Encephalomyelitis.

Run by Escuela Universitaria de Fisioterapia de la Once · NCT03675087 · Data updated 2026-11-12

This study is testing if a simple 6-minute walking test can help people with chronic fatigue syndrome understand their exercise limits without making their symptoms worse.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment22 (estimated)
SponsorEscuela Universitaria de Fisioterapia de la Once
Academic / other
Locations1 site (Madrid)
StatusRecruiting
StartedFebruary 27, 2019
Main results expectedJuly 2025
Study endsDecember 2025
Registry record updatedMarch 10, 2025
Trial IDNCT03675087 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with chronic fatigue syndrome/myalgic encephalomyelitis by a qualified medical specialist.

Probably not a fit

Patients with primary psychiatric disorders, somatoform disorders, or substance abuse issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study assesses the relationship between the 6-minute walking test (6MWT) and peak cardiopulmonary exercise testing (CPET) in individuals with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Participants will undergo a baseline physical activity assessment, followed by the 6MWT, and then the peak CPET two weeks later to evaluate exercise tolerance without exacerbating symptoms. The goal is to determine if the 6MWT can effectively measure exercise capacity while minimizing post-exertional malaise, which is a common issue with CPET. This research aims to identify a less stressful alternative for evaluating exercise tolerance in CFS/ME patients.

Why it matters

Potential benefit: If successful, this study could provide a safer and more effective method for assessing exercise tolerance in patients with chronic fatigue syndrome.

How similar studies have gone: While similar approaches have been explored, this specific correlation between the 6MWT and CPET in CFS/ME patients has not been adequately evaluated in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* To be diagnosed by a medical specialist in internal medicine with experience in this disease. For this, the participant must fulfill with the diagnostic criteria of CFS/ME, following the recommended criteria for the diagnosis of 2015.
* Prior signing of the informed consent.

Exclusion Criteria:

* Present any of the diagnoses considered excluding of the CFS/ME, according to the international criteria recommended for clinical diagnosis and the selection of subjects for research:

  * Primary psychiatric disorders
  * Somatoform disorders
  * or Substance abuse
* Present any of the absolute or relative contraindications, to perform exercise tests, described in previous investigations:

  * Decompensated heart failure
  * Acute myocardial infarction (less than 3 days)
  * Syncope
  * Unstable angina
  * Cardiac arrhythmia poorly controlled
  * Endocarditis, myocarditis or acute pericarditis
  * Acute pulmonary edema
  * Moderate or severe cardiac valvular stenosis
  * Suspected dissection or dissecting aortic aneurysm
  * O2 saturation at rest less than 85%
  * Acute renal failure
  * Untreated thyrotoxicosis
  * Acute infection
  * Uncontrolled hypertension (greater than 200-120 mmHg)
  * Hypertrophic obstructive cardiomyopathy
  * High-grade atrioventricular block
  * Significant pulmonary arterial hypertension
  * Advanced or risky pregnancy
  * Significant diselectrolithmia
  * Severe symptomatic aortic stenosis
  * Severe anemia
  * Pulmonary embolism
  * Acute thrombophlebitis
  * Traumatologic, orthopedic or neurological pathology that does not allow to walk or cycling.
  * Psychic incapacity to understand the instructions of the tests.
  * Present comorbidity of Multiple Chemical Sensitivity Syndrome.
  * Have performed the peak incremental CPET in the last 3 years.

Where it's running

  • Escuela Universitaria de Fisioterapia de la ONCE
    Madrid, Spain
    Recruiting

Study contacts

  • Principal investigator: Susana García-Juez — Escuela Universitaria de Fisioterapia de la Once
  • Study coordinator: Susana García-Juez, Lecturer
  • Email: sgj@once.es
  • Phone: 915894500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.